Is the use of colloids for fluid replacement harmless in children?

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Current Opinion in Anaesthesiology

• Publication date

  2010-06-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1097/ACO.0b013e328339384ePMID 20386439
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Colloid solutions for fluid resuscitation.

  2012cited by this paper
• Changes in acid‐base, electrolyte and hemoglobin concentrations during infusion of hydroxyethyl starch 130/0.42/6 : 1 in normal saline or in balanced electrolyte solution in children

  2010cited by this paper
• Equal effects of gelatin and hydroxyethyl starch (6% HES 130/0.42) on modified thrombelastography in children

  2009cited by this paper
• Influence of fluid therapy on the haemostatic system of intensive care patients.

  2009cited by this paper
• PRO: hydroxyethylstarch can be safely used in the intensive care patient—the renal debate

  2009cited by this paper
• Perioperative volume replacement in children undergoing cardiac surgery: Albumin versus hydroxyethyl starch 130/0.4*

  2009cited by this paper
• Effects of artificial colloids on haemostasis.

  2009cited by this paper
• Modern Rapidly Degradable Hydroxyethyl Starches: Current Concepts

  2009cited by this paper
• Relevance of non-albumin colloids in intensive care medicine.

  2009cited by this paper
• HES 130/0.4 (Voluven®) or human albumin in children younger than 2 yr undergoing non‐cardiac surgery. A prospective, randomized, open label, multicentre trial

  2008cited by this paper
• The role of tetrastarches for volume replacement in the perioperative setting

  2008cited by this paper
• Alteration of anion gap and strong ion difference caused by hydroxyethyl starch 6% (130/0.42) and gelatin 4% in children

  2008cited by this paper
• Colloid solutions for fluid resuscitation.

  2008cited by this paper
• Hydroxyethyl starch 130/0.42/6:1 for perioperative plasma volume replacement in children: preliminary results of a European prospective multicenter observational postauthorization safety study (PASS)

  2008cited by this paper
• Effects of albumin 5% and artificial colloids on clot formation in small infants

  2007cited by this paper
• Saline versus balanced hydroxyethyl starch: does it matter?

  2007cited by this paper
• A new plasma-adapted hydroxyethylstarch preparation: in vitro coagulation studies using thrombelastography and whole blood aggregometry.

  2007cited by this paper
• HES 130/0.42 shows less alteration of pharmacokinetics than HES 200/0.5 when dosed repeatedly.

  2007cited by this paper
• Drug Insight: the role of albumin in the management of chronic liver disease

  2007cited by this paper
• Gelatin and Hydroxyethyl Starch, but Not Albumin, Impair Hemostasis After Cardiac Surgery

  2006cited by this paper
• Volume Expansion with Albumin Compared to Gelofusine in Children with Severe Malaria: Results of a Controlled Trial

  2006cited by this paper
• Effects of intravascular volume therapy using hydroxyethyl starch (130/0.4) on post‐operative bleeding and transfusion requirements in children undergoing cardiac surgery: a randomized clinical trial

  2006cited by this paper
• Volume resuscitation: crystalloid versus colloid.

  2006cited by this paper
• Effects of hydroxyethyl starch on cardiac output in hypotensive neonates: A comparison with isotonic saline and 5% albumin

  2006cited by this paper
• Effects of intravascular volume therapy using hydroxyethyl starch (130/0.4) on post-operative bleeding and transfusion requirements in children undergoing cardiac surgery: a randomized clinical trial.

  2006cited by this paper
• Crystalloid or colloid for partial exchange transfusion in neonatal polycythemia: A systematic review and meta‐analysis

  2005cited by this paper
• Comparison of three fluid solutions for resuscitation in dengue shock syndrome.

  2005cited by this paper
• Randomized evaluation of fluid resuscitation with crystalloid (saline) and colloid (polymer from degraded gelatin in saline) in pediatric septic shock.

  2005cited by this paper
• Effects of Hydroxyethyl Starch Solutions on Hemostasis

  2005cited by this paper
• Systematic review of the optimal fluid for dilutional exchange transfusion in neonatal polycythaemia

  2005cited by this paper
• Pharmacokinetics of Hydroxyethyl Starch

  2005cited by this paper
• A comparison of albumin and saline for fluid resuscitation in the intensive care unit.

  2004cited by this paper
• Partitioning of TSE infectivity during ethanol fractionation of human plasma.

  2004cited by this paper
• Preferred plasma volume expanders for critically ill patients: results of an international survey

  2004cited by this paper
• A randomized, controlled study of fluid management in infants and toddlers during surgery: hydroxyethyl starch 6% (HES 70/0.5) vs lactated Ringer's solution.

  2003cited by this paper
• A randomized, controlled study of fluid management in infants and toddlers during surgery: hydroxyethyl starch 6% (HES 70/0.5) vs lactated Ringer's solution 1

  2003cited by this paper
• A randomized, blinded trial comparing the hemostatic effects of pentastarch versus hetastarch

  2002cited by this paper
• Acute management of dengue shock syndrome: a randomized double-blind comparison of 4 intravenous fluid regimens in the first hour.

  2001cited by this paper
• Reduction in case fatality rate from meningococcal disease associated with improved healthcare delivery

  2001cited by this paper
• Patient survival after human albumin administration. A meta-analysis of randomized, controlled trials.

  2001cited by this paper
• Use of albumin, blood transfusion and intraoperative glucose by APA and ADARPEF members: a postal survey

  2001cited by this paper
• [Intraoperative fluid therapy in infants and young children].

  1999cited by this paper
• Fluid resuscitation with colloid or crystalloid solutions in critically ill patients: a systematic review of randomised trials

  1998cited by this paper
• Réactions anaphylactoïdes aux substituts colloïdaux du plasma : incidence, facteurs de risque, mécanismes. Enquête prospective multicentrique française

  1994cited by this paper
• [Anaphylactoid reactions to colloid plasma substitutes: incidence, risk factors, mechanisms. A French multicenter prospective study].

  1994cited by this paper

• Fluid bolus resuscitation with hypertonic saline albumin solution in critically ill children: a prospective observational pilot study

  2024cites this paper
• Perioperative management of fluids and electrolytes in children.

  2023cites this paper
• Perioperative fluid management in children: an updated review

  2022cites this paper
• in Children Undergoing Surgery and Anesthesia

  2019cites this paper
• Choc hémorragique chez l’enfant

  2016cites this paper
• Priming the bypass circuit

  2015cites this paper
• Impact of 6% hydroxyethyl starch 130/0.42 and 4% gelatin on renal function in a pediatric animal model

  2014cites this paper
• Fluid Management in Pediatric Patients

  2013cites this paper
• Effect of rapid fluid resuscitation using crystalloids or colloids on hemostasis in piglets

  2013cites this paper
• Hydroxyethyl starch 130/0.42/6:1 for perioperative plasma volume replacement in 1130 children: results of an European prospective multicenter observational postauthorization safety study (PASS).

  2012cites this paper
• Isovolaemic hemodilution with gelatin and hydroxyethylstarch 130/0.42: effects on hemostasis in piglets

  2012cites this paper
• [On water, salt and more … infusion therapy for neonates, infants and children].

  2011cites this paper
• Über Wasser, Salz und mehr …

  2011cites this paper